Title: Alterations in Serum Lipid Profile & Lipid Peroxidation Status in Female Breast Tumour Patients

Authors: Dr Sanghamitra Bhoi, Dr Jyotindra Kumar Sahu, Dr Pramila Kumari Mishra, Dr Manmath Kumar Mandal

 DOI:  https://dx.doi.org/10.18535/jmscr/v5i7.93

Abstract

Breast Carcinoma is the most common cause of death in middle aged women in western countries. In India it is the second most common carcinoma in female next to cervical carcinoma. Our aim was to evaluate the relationship of lipid profile and Lipid peroxidation status with breast tumour. These findings suggest that obesity is not an important risk factor in development breast tumour. Early menarche, late menopause and low parity are definite risk factors. Dyslipidemia  is definitely  associated  with  breast tumour  whether  it is a  cause  or effect of  tumour it  is  not  exactly  known. There  is  definite increase  in ROS  production  oxidative  stress  is  more in case  of  breast  tumour  patients  both  in  benign  and  malignant group.

Keywords:  Lipid profile, Malondialdehyde & breast tumour.

References

1.      Ramzi .S .Cortan, Vinay  kumar ,Stanley L. Robbins , Neoplasia .In Robbins Pathologic basis of  diseases . Etdby  Schoen  F.J .  8thEdn  . 2009  .Prism  book  Pvt .  Ltd . 261-295 .

2.      Richard Sainsbury,The Breast   .In  Baily  Love`s short  practice  of surgery ,revised  by Norman S. Willium,Christopher J.K Bulstrode,P.Ronon, O.Connel. 25th Edn.-2008 :827.

3.     Park K. Epidemiology  of   chronic non  communicable   diseases and  conditions  In: Park’s textbook of preventive and social medicine. 20th ed. Park K. Jabalpur: M/s BanarasidasBhanot; 2009. p. 333-337.

4.      ICMR  Bulletin, Estrogen and breast  cancer   Feb 2003,vol 33(2):  13-16.

5.      Goedegebuure  P.S , Eberlein  T .J , Tumour Biology  and  tumour  Markers .In  Sabiston  text  book  of  Surgery .Etd. by Townsend   M.C .,Beauchamp R.D . Evers  B.M ,Mattox  L.K , 17 *   Edn.  2008, Harcourt  Asia Pvt. Ltd.:485.

6.      Armstrong  B, Doll  R ,Environmental  factors  and  cancer  incidence  and mortality in  different  countries  with  special  reference  to dietary  practices.Int J cancer 1975,15,617-621.

7.      Jain D , Ray A ,  Bahadur  A.K , Chaturbedi K.U , Sood R , Sharma S ,NaikS.L.O.SharmaB.K..Status  of  epidermal  growth  factor  receptors family  in hormone  dependent  carcinomas  of  the breast  and  prostate  with  reference  to serum  lipids  and  lipoproteins .Indian  journal  of  clinical  Biochemistry ,2001,16(1):42-51.

8.      Marnett LJ. Oxyradicalsand  DNA damage .Carcinogenesis 2000 ;21:361-371.

9.      Guyton K.Z .Kensler T.W . oxidative  damage  in carcinogenesis  .British Medical  Bulletin 1993 ; 49:523-544.

10.  Mehta G. Kothari , S .Singh in developing  population ;A  nutrition caveat. Indian journal  of clinical  Biochemistry ,2001;16(1):65-71.

11.  Kumar V, Abbas AK, Fausto N, Mitchell R. Robbins basic pathology.The breast  tumours . 8th edn. Philadelphia: Saunders Elsevier; 2009. p.1068-1069.

12.  Ma, H., Bernstein, L., Pike, MC., Ursin, G.,Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies. Breast Cancer Res 2006; 8:R43.

13.  Alan Potter J  Katherine  Gallahen A. Flow cytometric of the cell cycle ,phase  specificity  of  DNA  damage induced by radiation, Hydrogen  peroxide and  Doxorubicin  and  carcinogenesis, 2003, 24(2) 235-241.

14.  Fletcher M J. Determination of serum Triglyceride. Clin Chem Acta. 1968;22:293

15.  Zlatkis A, Zak B, Boyle J. Estimation of serum HDL-cholesterol. Lab Clin Med 1953:41:486

16.  Friedwald W T, Levy R I, Estimation of concentration of low density lipoprotein cholesterol in plasma, without use of the preparative centrifuse. Clin Chem 1972:18:499-502.

17.  Guyton K.Z .Kensler T.W . oxidative  damage  in carcinogenesis  .British Medical  Bulletin 1993 ; 49:523-544.

18.  Metcalfe K, Lynch HT, Ghadirian P, et al. Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. J Clin Oncol 2004;22:2328–35.

19.  Croce CM (January 2008). "Oncogenes and cancer". The New England journa medicine 358(5) : 50211. doi : 10.1056 / NEJ Mra 072367. PMID 18234754.

20.  Ross, RK., Paganini-Hill, A., Wan, PC., Mike, PC.,Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin J Natl Cancer Inst 2000. 92:328-32

21.  Chan, MF., Dowsett, M., Folkerd, E., et alUsual physical activity and endogenous sex hormones in postmenopausal women: the European prospective investigation into cancer-norfolk population study Cancer Epidemiol Biomarkers Prev 2007. 16:900-5

22.  Varley H. Determination of Total, free and easter cholesterol, using reaction with ferric chloride and sulphuric acid. In: Varley H. Practical Clinical Biochemistry. 4th ed. CBS publisher and distributors: Asia Printograph, 1988:309-326

23.  Garrow  J .S,  Webster  J .  Qutelet s index as a  measure of fatness.   International  journal  of  obesity .1985 ;9 147-153.

24.  Stephen .N. Bunt  J.C .,Salbe .A .D, Fuhanasi J, Matsuzawa. Y and Tattaranni  P.A . Plasma  adiponectin  concentration  and its relationship with obesity  and  carcinoma .Journal  of  clinical  endocrinology  and  metabolism.,2006 ,87: 4652-4656.

25.  Yager JD; Davidson NE (2006). "Estrogen carcinogenesis in breast cancer". New Engl J Med 354(3): 270–  82 

26.  Mayes P.A ,Lipid transport  and  storage.Etd by  Murray  R.K. ,Granner  D.K, Mayes P.A  ,Rodwell  V.W .28  th Edn .2009, Appelton &  Lange Publn: 268-272.

27.  D.M .Vasudevan, Sreekumari  S ,Kannan Vaidyanathan  ;Cholesterol and Lipoprotein ; In Text book of  Biochemistry ,6th  Edn P:144-149

28.  Bani I.A., Williams, C.M., Boulter P.S., Dickerson J.W.T.,(1986).Plasma lipids and prolactin in patients with breast cancer. Br. J. Cancer, 54:439-446.

29.  Leena Hilakivi-Clarke , Estrogens, BRCA 1 ,BRCA 2 &  Breast  cancer . Cancer  Research  2000 ; 60  4993-5001 .

30.  National heart ,lung and blood  institute, clinical  guidelines   on  identification, evaluation  and  treatment  of  overweight  and  obesity in  adults   NIH  publication no.98-4083.       

31.  Lahmann, PH., Friedenreich, C., Schuit, AJ., et alPhysical activity and breast cancer risk: the European Prospective Investigation into Cancer and Nutrition Cancer Epidemiol Biomarkers Prev 2007. 16:36-42

32.  Dong, J. Y. and Qin, L. Q..,Soy isoflavones consumption and risk of breast cancer incidence or recurrence: a meta-analysis of prospective studies Breast Cancer Res Treat 2011. 125(2):315-23

33.  History of cancer   American cancer society .2002-3-05.Retrieved 2006-10-09.

34.  Satoh K (1978). Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clin ChimActa, 90(1): 37-43.

35.  Tanner, J.M. Trend towards earlier menarche in London, Oslo, Copenhagen, the Netherlands and Hungary. Nature 1973; 243; 5402; 95-6.

36.  Andrieu N, Prevost T, Rohan TE, et al. Variation in the interaction between familial and reproductive factors on the risk of breast cancer according to age, menopausal status, and degree of familiality. Int J Epidemiol 2000;29:214–23.

37.  Tamimi, RM., Byrne, C., Colditz, GA., Hankinson, SE.,Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women J Natl Cancer Inst 2007. 99:1178-87.

38.  Layde, PM., Webster, LA., Baughman, Al., Wingo, PA., et al; The independent associations of parity, age at first full term pregnancy, and duration of breastfeeding with the risk of breast cancer. Cancer and Steroid Hormone Study Group. J Clin Epidemiol 1989; 42:963-73

Corresponding Author

Dr Jyotindra Kumar Sahu

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.